|
Post by maddass98 on May 19, 2016 14:10:13 GMT -5
i just look at twitter, there is no such tweet from him on twitter! he must have deleted it!
|
|
|
Post by nylefty on May 19, 2016 14:20:12 GMT -5
|
|
|
Post by prvs on May 19, 2016 14:22:11 GMT -5
It happened. I'll let the others talk about it. May be that Chinese investor was feeding Matt his own medicine of stay tuned to get some talk time I have no doubt that it happened, I just question the validity of the offer.
|
|
|
Post by brentie on May 19, 2016 14:22:20 GMT -5
|
|
|
Post by nylefty on May 19, 2016 14:36:47 GMT -5
Somebody posted the following on the Yahoo board:
kevinmik • 2 minutes 17 seconds ago
Sharholder Meeting Highlights
Michael Castaglia Presentation & Chinese Investment Group Offering To Make Equity Investment In Mannkind
Overall the meeting was very positive and I would say Michael Castaglia's presentation on the company's commercial strategy was one of the highlights. The guy knows his stuff and he was very impressive & articulate explaining his strategy. Mannkind is very lucky to have hired him.
Shareholders who were in attendance seemed for the most part to be supportive of Mannkind's 2.0 strategy. The one highlight in the meeting that caught me by complete surprise was during the Q&A session when a gentleman stood up identifying himself as a friend & former business partner of Alfred Mann having served on a Board of Directors with Al for an Aerospace Company and he also identified himself as a current member of Chinese Investment Group and he went on to make a very public offer to Mannkind at the meeting that his investment firm wants to make a sizable investment in Mannkind and would like to speak to Mannkind.
Matt Pfeffer seemed taken back by the statement and did not respond except to say the gentleman really did not ask a question. It will be interesting to see if this goes anywhere or if it gets pick up by the media about Mannkind getting a public investment offer at the meeting. Here is some highlights surrounding the meeting.
- all agenda items voted on were approved by shareholders - Mannkind's Chairman started off the meeting and handled official voting segment. - Matt Pfeffer spoke but did not offer anything new - Michael Castaglia was the only other member of management to speak at the meet and he was great - small convenient spirometry device costing $350 to be promoted was shown at the meeting - new sample pack was was shown at the meeting - Mannkind will have a big presence at ADA Meeting - clamp studies completed will be used for label updates - industry layoff benefiting Mannkind hiring & Astra reps likely to shift onto Afrezza - DTC marketing will be done locally targeting community sponsorship events. - Tribute to Alfred Mann & unveiled statue of Al
|
|
naykitop
Newbie
Posts: 14
Sentiment: Long
|
Post by naykitop on May 19, 2016 14:50:18 GMT -5
Somebody posted the following on the Yahoo board: kevinmik • 2 minutes 17 seconds ago
Sharholder Meeting Highlights
Michael Castaglia Presentation & Chinese Investment Group Offering To Make Equity Investment In Mannkind
Overall the meeting was very positive and I would say Michael Castaglia's presentation on the company's commercial strategy was one of the highlights. The guy knows his stuff and he was very impressive & articulate explaining his strategy. Mannkind is very lucky to have hired him.
Shareholders who were in attendance seemed for the most part to be supportive of Mannkind's 2.0 strategy. The one highlight in the meeting that caught me by complete surprise was during the Q&A session when a gentleman stood up identifying himself as a friend & former business partner of Alfred Mann having served on a Board of Directors with Al for an Aerospace Company and he also identified himself as a current member of Chinese Investment Group and he went on to make a very public offer to Mannkind at the meeting that his investment firm wants to make a sizable investment in Mannkind and would like to speak to Mannkind.
Matt Pfeffer seemed taken back by the statement and did not respond except to say the gentleman really did not ask a question. It will be interesting to see if this goes anywhere or if it gets pick up by the media about Mannkind getting a public investment offer at the meeting. Here is some highlights surrounding the meeting.
- all agenda items voted on were approved by shareholders - Mannkind's Chairman started off the meeting and handled official voting segment. - Matt Pfeffer spoke but did not offer anything new- Michael Castaglia was the only other member of management to speak at the meet and he was great - small convenient spirometry device costing $350 to be promoted was shown at the meeting - new sample pack was was shown at the meeting - Mannkind will have a big presence at ADA Meeting - clamp studies completed will be used for label updates - industry layoff benefiting Mannkind hiring & Astra reps likely to shift onto Afrezza - DTC marketing will be done locally targeting community sponsorship events. - Tribute to Alfred Mann & unveiled statue of Al Thank you for the objective summary on the meeting. Agree, the Chinese investor comments is a bit strange and glad Matt didn't respond to it.
|
|
|
Post by pengiep on May 19, 2016 15:03:08 GMT -5
I wonder if some of the very clever sleuths on this board might be able to propose some candidates for the identity & validity of the guy making the investment offer. There have to be a limited number of people who have served with Al on the BoD of aerospace firms in the last 10 years. And it should not be hard to see what they are up to. I wonder if they are on linked in?
|
|
|
Post by roseylv on May 19, 2016 15:04:12 GMT -5
All serious long shareholders pretty much realize that this so called, "Chinese investor" is a prop or pawn in a scheme of some sort. If it pans out for the best, then great! Otherwise, disregard the noise. I"m sure somebody has emailed Matt for comment and alls he'll say is, "NO COMMENT" lol.
|
|
|
Post by nylefty on May 19, 2016 15:14:05 GMT -5
Do people who post LOL after their comments actually Laugh Out Loud at how clever they think they are?
|
|
|
Post by sportsrancho on May 19, 2016 15:29:13 GMT -5
- during Q&A a women read a statement about SEC investment including insider trading violation and Matt answered stating company is aware of short sales investigation, but never heard anything about insider trading violations. - Mat asked if company has a final termination agreement including compensation for Sanofi sabotaged launch and he said they have a termination agreement getting Afrezza back, but could not discuss any monetary arrangements/discussion/strategies and said say tune. - Michael Castaglia presented a very thorough commercial strategy that will build on what Sanofi did not do, did wrong and would target healthcare provider education, Endo's and an easier/faster patient 1st time user experience for Afrezza. He is introducing the low cost Spirometry to healthcare providers and a 24/7 Afrezza Service Line, whereby, doctors and patients can get prior authorization done and patients filing their 1st prescriptions a quickly as 72 hours. - Q&A someone brought up an interesting suggestion Mannkind should use Pfizer Insulin to make Afrezza available outside the U.S. in 3rd world countries with the help of the Gates Foundation, not so much to make money, but to get Afrezza used globally to demonstrate its paradigm changing benefits. - tour of the manufacturing plant was truly impressive and its a state of the art facility.What Mannkind is doing in Danbury is unmatched in the industry and likely cannot be matched exactly by big pharma. Generic competition will be very difficult and it will keep Mannkind protected long after patent expiration. - shareholders at the meeting blaming Sanofi for Afrezza failed launch.
|
|
|
Post by mnkdfann on May 19, 2016 15:41:55 GMT -5
How many people were at the meeting? Several dozen? Hundreds?
|
|
|
Post by als57 on May 19, 2016 15:45:38 GMT -5
As I recall at last years ASM, Al Mann spoke about a cheap spirometer that could easily be manufactured and meet the FDA's requirements.
|
|
|
Post by esstan2001 on May 19, 2016 15:50:52 GMT -5
How many people were at the meeting? Several dozen? Hundreds? I estimate 250ish
|
|
|
Post by tingtongtung on May 19, 2016 15:54:23 GMT -5
Didn't several people from here attend the meeting? Kevinmik (yahoo) seems to be the only first-hand info I have seen so far..
BTW, what's up with this Chinese guy? How can such a thing even happen, unless that guy is crazy, wants attention, facebook narcissist, or a dare.. Chinese are not some village idiots trying to buy a company as if its milk in grocery store. Didn't WDC wait for *several* days to get SNDK acquisition approval from Chinese last week? I don't buy any more conspiracies on this.
I believe MNKD and Afrezza, and the current management. I hope they start selling ASAP.
|
|
|
Post by esstan2001 on May 19, 2016 15:55:37 GMT -5
As I recall at last years ASM, Al Mann spoke about a cheap spirometer that could easily be manufactured and meet the FDA's requirements. That's correct. So the new guy Mike showed a nice $350 unit that they will promote via nurse practitioners, website, etc. and have a sample (audience shareholder suggested 10-15 for touchy-feely) laying around at the ADA booth.
|
|